Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones

Chia Chung Lee, Fei Lan Liu, Chun Liang Chen, Tsung Chih Chen, Feng Cheng Liu, Ahmed Atef Ahmed Ali, Deh Ming Chang, Hsu Shan Huang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A series of novel 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives were synthesized and evaluated for their inhibitory effects on osteoclast activities by using TRAP-staining assay. Among the tested compounds, 3d and 3h exhibited more potent osteoclast-inhibitory activities than the lead compound NDMC503 (a ring-fused structure of NDMC101), as reported in our previous study. Both 3d and 3h exhibited two-fold increase in activity compared to NDMC503. In addition, our biological results indicated that 3d and 3h could suppress RANKL-induced osteoclastogenesis-related marker genes, such as NFATc1, c-fos, TRAP, and cathepsin K. Notably, 3d could significantly attenuate the bone-resorbing activity of osteoclasts in the pit formation assay. Thus, this study might provide a new class of lead structures that warrant further development as potential anti-resorptive agents.

Original languageEnglish
Pages (from-to)4522-4532
Number of pages11
JournalBioorganic and Medicinal Chemistry
Volume23
Issue number15
DOIs
Publication statusPublished - Jul 23 2015

Fingerprint

Oxazines
Osteoclasts
Osteogenesis
Assays
Cathepsin K
Lead compounds
Genes
Staining and Labeling
Derivatives
oxazine 1
Lead

Keywords

  • NDMC101
  • Osteoclastogenesis
  • Pit formation assay
  • RANKL
  • TRAP-staining assay

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Novel inhibitors of RANKL-induced osteoclastogenesis : Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones. / Lee, Chia Chung; Liu, Fei Lan; Chen, Chun Liang; Chen, Tsung Chih; Liu, Feng Cheng; Ahmed Ali, Ahmed Atef; Chang, Deh Ming; Huang, Hsu Shan.

In: Bioorganic and Medicinal Chemistry, Vol. 23, No. 15, 23.07.2015, p. 4522-4532.

Research output: Contribution to journalArticle

Lee, Chia Chung ; Liu, Fei Lan ; Chen, Chun Liang ; Chen, Tsung Chih ; Liu, Feng Cheng ; Ahmed Ali, Ahmed Atef ; Chang, Deh Ming ; Huang, Hsu Shan. / Novel inhibitors of RANKL-induced osteoclastogenesis : Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones. In: Bioorganic and Medicinal Chemistry. 2015 ; Vol. 23, No. 15. pp. 4522-4532.
@article{0f057d11c6ba4f1e9a41944614292aa5,
title = "Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones",
abstract = "A series of novel 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives were synthesized and evaluated for their inhibitory effects on osteoclast activities by using TRAP-staining assay. Among the tested compounds, 3d and 3h exhibited more potent osteoclast-inhibitory activities than the lead compound NDMC503 (a ring-fused structure of NDMC101), as reported in our previous study. Both 3d and 3h exhibited two-fold increase in activity compared to NDMC503. In addition, our biological results indicated that 3d and 3h could suppress RANKL-induced osteoclastogenesis-related marker genes, such as NFATc1, c-fos, TRAP, and cathepsin K. Notably, 3d could significantly attenuate the bone-resorbing activity of osteoclasts in the pit formation assay. Thus, this study might provide a new class of lead structures that warrant further development as potential anti-resorptive agents.",
keywords = "NDMC101, Osteoclastogenesis, Pit formation assay, RANKL, TRAP-staining assay",
author = "Lee, {Chia Chung} and Liu, {Fei Lan} and Chen, {Chun Liang} and Chen, {Tsung Chih} and Liu, {Feng Cheng} and {Ahmed Ali}, {Ahmed Atef} and Chang, {Deh Ming} and Huang, {Hsu Shan}",
year = "2015",
month = "7",
day = "23",
doi = "10.1016/j.bmc.2015.06.007",
language = "English",
volume = "23",
pages = "4522--4532",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "15",

}

TY - JOUR

T1 - Novel inhibitors of RANKL-induced osteoclastogenesis

T2 - Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones

AU - Lee, Chia Chung

AU - Liu, Fei Lan

AU - Chen, Chun Liang

AU - Chen, Tsung Chih

AU - Liu, Feng Cheng

AU - Ahmed Ali, Ahmed Atef

AU - Chang, Deh Ming

AU - Huang, Hsu Shan

PY - 2015/7/23

Y1 - 2015/7/23

N2 - A series of novel 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives were synthesized and evaluated for their inhibitory effects on osteoclast activities by using TRAP-staining assay. Among the tested compounds, 3d and 3h exhibited more potent osteoclast-inhibitory activities than the lead compound NDMC503 (a ring-fused structure of NDMC101), as reported in our previous study. Both 3d and 3h exhibited two-fold increase in activity compared to NDMC503. In addition, our biological results indicated that 3d and 3h could suppress RANKL-induced osteoclastogenesis-related marker genes, such as NFATc1, c-fos, TRAP, and cathepsin K. Notably, 3d could significantly attenuate the bone-resorbing activity of osteoclasts in the pit formation assay. Thus, this study might provide a new class of lead structures that warrant further development as potential anti-resorptive agents.

AB - A series of novel 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives were synthesized and evaluated for their inhibitory effects on osteoclast activities by using TRAP-staining assay. Among the tested compounds, 3d and 3h exhibited more potent osteoclast-inhibitory activities than the lead compound NDMC503 (a ring-fused structure of NDMC101), as reported in our previous study. Both 3d and 3h exhibited two-fold increase in activity compared to NDMC503. In addition, our biological results indicated that 3d and 3h could suppress RANKL-induced osteoclastogenesis-related marker genes, such as NFATc1, c-fos, TRAP, and cathepsin K. Notably, 3d could significantly attenuate the bone-resorbing activity of osteoclasts in the pit formation assay. Thus, this study might provide a new class of lead structures that warrant further development as potential anti-resorptive agents.

KW - NDMC101

KW - Osteoclastogenesis

KW - Pit formation assay

KW - RANKL

KW - TRAP-staining assay

UR - http://www.scopus.com/inward/record.url?scp=84937817628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937817628&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2015.06.007

DO - 10.1016/j.bmc.2015.06.007

M3 - Article

C2 - 26081760

AN - SCOPUS:84937817628

VL - 23

SP - 4522

EP - 4532

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 15

ER -